脑部放疗，上午比下午敏感许多！
2 i- W5 ?6 f c- J# K1 v7 F9 G/ i0 W8 v; K$ V
7 `$ w2 ?) s* D$ fCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
- s! J+ ]) C) Y& A" CGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
6 }( S! @5 M( X* x) PRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
% k7 c/ q& m* mSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.3 ~ P+ S( G2 f+ y* W8 b+ J0 p
+ }- V8 U8 c' Q, Z( S1 X0 ~Abstract
5 } p$ U* L. _1 {" O' L- i5 TBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.$ U( K& x9 s; k. l4 [9 t5 u
' m; B. Q8 _" @- U" ]
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
" f p( Z% A0 _, L3 O* U) \; S* T
2 H4 \0 d- o! o; g$ g; hRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
/ j! ]& }2 ]7 H8 D2 Y4 \' X! {6 a2 S& s2 u, W, Y" V
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series. R: n' G9 ^ t
& l* [5 H. i+ X2 N- \7 c/ k3 ^; h |
显身卡
